Thereafter, we reported the in vivo reduction in neutrophil elastase (NE) and myeloperoxidase (MPO) in neutrophils from RA patients after six months of treatment with the IL-6R inhibitor tocilizumab [39]. The gene discussed is IL6R; the disease is rheumatoid arthritis.